During Novozymes' virtual capital markets day held Tuesday afternoon, the company's chief executive said that it's not merely an enzyme producer, but much more than that.
According to CEO Ester Baiget, it's only logical to equate Novozymes with enzyme production. But the company doesn't see itself in that way. This is evident in a new strategy meant to boost the company ahead of 2025 and, not least, lay to rest the past six years, which have not at all lived up to the company's expectations – an aspect also highlighted by Baiget.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for EnergyWatch has now started
With your free trial you get:
Full access to all locked articles on EnergyWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.